Jennie Stuart Health Neurology is now offering patients access to cutting-edge testing and technology to aid in the diagnosis and treatment of Alzheimer’s.
Alzheimer’s disease is a progressive brain disorder that slowly degrades memory, thinking and other cognitive functions, and its exact cause is still unknown. While there is no known cure for the disease, certain medications and therapies can help manage symptoms and possibly slow the progression of the disease.
One way to get ahead of the disease is to diagnose it as soon as possible, and now, Jennie Stuart Health Neurology is offering the pTau 217 lab test to do just that. The test is considered a breakthrough in early detection of Alzheimer’s, and can help identify the disease in its earliest stages, long before significant symptoms appear.
In addition to diagnostic testing, Jennie Stuart Neurology now offers innovative infusion therapies that target the underlying cause of Alzheimer’s disease. These treatments work by reducing amyloid plaque deposits in the brain, which is one of the main drivers of memory loss and neurodegeneration.
Neurologist Dr. Paresh Sheth says, “For the first time, we have therapies that don’t just manage symptoms— they address the disease process itself. By combining advanced diagnostic tools like the pTau 217 test with these targeted treatments, we can intervene earlier and give patients a better chance at preserving their cognitive health and quality of life.”